Cargando…
A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination
Autores principales: | Sriskandarajah, Priya, Hobart, Jess, Radia, Deepti H., Whyte, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517291/ https://www.ncbi.nlm.nih.gov/pubmed/34667940 http://dx.doi.org/10.1097/HS9.0000000000000650 |
Ejemplares similares
-
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021
por: Saunders, Jamie, et al.
Publicado: (2021) -
P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE
por: Reiter, A., et al.
Publicado: (2022) -
Anesthetic experience in a pediatric patient with mastocytosis
por: Jo, Youn Yi, et al.
Publicado: (2011) -
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022) -
SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
por: Tuncay, Gülseren, et al.
Publicado: (2022)